• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR CORK UNKNOWN_NEUROVASCULAR_PRODUCT; CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR CORK UNKNOWN_NEUROVASCULAR_PRODUCT; CATHETER, PERCUTANEOUS Back to Search Results
Catalog Number UNK_NEU
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Anaphylactic Shock (1703); Stroke/CVA (1770); Hematoma (1884); Intracranial Hemorrhage (1891); Inflammation (1932); Intraocular Infection (1933); Sepsis (2067); Transient Ischemic Attack (2109); Vasodilatation (2127); Obstruction/Occlusion (2422); Pseudoaneurysm (2605); Vascular Dissection (3160); Embolism/Embolus (4438); Thrombosis/Thrombus (4440)
Event Date 07/12/2023
Event Type  Injury  
Manufacturer Narrative
H3 other text : the device is not available for evaluation.
 
Event Description
The survey conducted in france, italy, and united states.Results from the survey stated that adverse events (intracranial hemorrhage, access site complications, stroke, transient ischemic attack (tia), vessel dissection, vessel perforation, pseudoaneurysm, acute vessel occlusion/ischemia, vasospasm, emboli, thrombosis, fever, inflammation of the puncture site, allergic reaction requiring additional medical treatment(s), infection of the puncture site requiring oral or systematic antibiotics, and hematoma) were reported.No other information was provided.
 
Manufacturer Narrative
Although the dhr could not be reviewed because the lot number remains unknown, there are controls in the manufacturing process to ensure the product met specifications upon release.The subject device is not available; therefore, visual and functional testing as well as physical analysis cannot be performed.The reported complaint could not be confirmed, and it could not be definitively determined if the device failed to meet specifications because the product was not returned.The reported event is covered in the device directions for use (dfu).As well, the risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.It was reported that a post-market clinical follow-up (pmcf) survey was conducted for long sheath catheters (device numbers: unknown, quantity: (b)(4) and long sheath catheters plus (device unknown, quantity: (b)(4) and responses (double blinded) from physicians was received on (b)(6) 2023.Events of patient stroke, patient tia (transient ischemic attack), patient vessel dissection, patient vessel perforation, patient vessel occlusion, patient vasospasm non-serious, patient embolus, patient inflammation, patient infection and vascular access site complications non-serious were reported from clinical specialists involved in the survey were from italy, france, and united states.Based upon medical review, the reported events are observed in this complaint is anticipated in nature as per the device risk assessment.As a product related root cause does not apply and the issue is due to a known physiological effect of the procedure and/or patient condition noted within the dfu, product labeling and/or risk documentation files, an assignable cause of anticipated procedural complication will be assigned to reported events of patient stroke, patient tia (transient ischemic attack), patient vessel dissection, patient vessel perforation, patient vessel occlusion, patient vasospasm non-serious, patient embolus, patient inflammation, patient infection and vascular access site complications non-serious.
 
Event Description
The survey conducted in france, italy, and united states.Results from the survey stated that adverse events (intracranial hemorrhage, access site complications, stroke, transient ischemic attack (tia), vessel dissection, vessel perforation, pseudoaneurysm, acute vessel occlusion/ischemia, vasospasm, emboli, thrombosis, fever, inflammation of the puncture site, allergic reaction requiring additional medical treatment(s), infection of the puncture site requiring oral or systematic antibiotics, and hematoma) were reported.No other information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN_NEUROVASCULAR_PRODUCT
Type of Device
CATHETER, PERCUTANEOUS
Manufacturer (Section D)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI  NA
Manufacturer (Section G)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI   NA
Manufacturer Contact
tara lopez
47900 bayside parkway
fremont, CA 94538
5104132500
MDR Report Key17371668
MDR Text Key319502734
Report Number3008881809-2023-00369
Device Sequence Number1
Product Code DQY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K152876
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/04/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK_NEU
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/12/2023
Initial Date FDA Received07/21/2023
Supplement Dates Manufacturer Received09/25/2023
Supplement Dates FDA Received10/04/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-